Real‐world long‐term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection

BACKGROUND AND AIM: This study aimed to evaluate the long‐term clinical course of patients achieving a sustained virologic response (SVR) with daclatasvir plus asunaprevir (DCV/ASV) therapy. METHODS: A total of 911 patients who achieved SVR with DCV/ASV were assessed. To evaluate pretreatment factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Hideki, Kimura, Hiroyuki, Hasebe, Chitomi, Akahane, Takehiro, Satou, Takashi, Kusakabe, Atsunori, Kojima, Yuji, Kondo, Masahiko, Marusawa, Hiroyuki, Kobashi, Haruhiko, Tsuji, Keiji, Ogawa, Chikara, Uchida, Yasushi, Joko, Kouji, Mitsuda, Akeri, Kurosaki, Masayuki, Izumi, Namiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120887/
https://www.ncbi.nlm.nih.gov/pubmed/35601120
http://dx.doi.org/10.1002/jgh3.12749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120887/
https://www.ncbi.nlm.nih.gov/pubmed/35601120
http://dx.doi.org/10.1002/jgh3.12749

Ejemplares similares